News

Men are more likely than women to die of ‘broken heart syndrome’: Study
A new study from the Journal of the American Heart Association found that men die from a condition known as “broken heart syndrome” at more than twice the rate that women do.
Healthline19h
Males Two Times as Likely to Die From ‘Broken Heart Syndrome,’ Study Finds
Broken heart syndrome” carries a significant risk of death and serious complications. Although the condition appears to be ...
What is 'broken heart syndrome'? Study says though prevelant among women, more men die from it
A new study analyzing nearly 200,000 U.S. cases from 2016 to 2020 found that men are more than twice as likely to die from ...
The Cardiology Advisor9d
FDA Decision on Barth Syndrome Therapy Delayed Again
The FDA has communicated to Stealth BioTherapeutics that it would not meet elamipretide’s PDUFA target date for the treatment of Barth syndrome.
Healthline16d
Understanding Irritable Bowel Syndrome (IBS) in Older Adults
Irritable bowel syndrome, commonly referred to as IBS, is a condition in which multiple symptoms appear together, creating recurring abdominal pain and bowel dysfunction. Common symptoms include ...
contemporarypediatrics17d
Elamipretide to treat Barth syndrome sees FDA target action delay
This week, Stealth BioTherapeutics Inc. announced that the FDA did not meet the April 29, 2025, Prescription Drug User Fee Action (PDUFA) date for elamipretide's new drug application (NDA) to treat ...
The Pharma Letter17d
FDA misses decision deadline on Stealth’s Barth syndrome drug
US biotech firm Stealth BioTherapeutics (OTCQB: MITO) is facing renewed uncertainty after the American medicines regulator failed to deliver a decision on the company’s new drug application for ...
FDA delays decision on Stealth BioTherapeutics' rare genetic disorder drug
The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment for a rare genetic condition that typically affects boys, the drug developer ...
Yahoo17d
FDA misses approval deadline for biotech’s rare disease drug
The exterior of the Food and Drug Administration headquarters is seen on July 20, 2020 in White Oak, Maryland. 35,180 people played the daily Crossword recently. Can you solve it faster than others?35 ...